PulseAugur
EN
LIVE 22:40:51
中文(ZH) 第四批全国中成药联盟采购开标，覆盖89种临床常用药品

National TCM procurement results announced, covering 89 drugs

By PulseAugur Editorial · [1 sources] ·

The fourth batch of national centralized procurement for traditional Chinese medicine products concluded with a bid opening in Wuhan on April 30th, resulting in proposed winning selections. This procurement initiative included 89 drugs across 28 categories, with over 40,000 medical institutions reporting their needs. A total of 310 products from 243 companies were selected, indicating broad participation and the inclusion of commonly used clinical medications. AI

RANK_REASON This is a report on a government procurement process for traditional Chinese medicine, which is a policy-related event but not a major AI development.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

National TCM procurement results announced, covering 89 drugs

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
This is a report on a government procurement process for traditional Chinese medicine, which is a policy-related event but not a major AI development.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
policy, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
149 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    The fourth batch of national centralized procurement of traditional Chinese patent medicines opens bids, covering 89 clinically common drugs

    4月30日，第四批全国中成药联盟采购在武汉开标产生拟中选结果。本次集采纳入28个采购组89种药品，全国4万余家医药机构参与报量。共有344家企业的468个产品符合投标条件，243家企业的310个产品中选。总体来看，企业投标积极踊跃，中选剂型规格齐全，当前临床使用的主流产品普遍中选，可有效满足临床用药需求。（界面）

RELATED TOPICS